A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

por López, R, Salgado, M, Reboredo, M, Grande, C, Méndez, J C, Jorge, M, Romero, C, Quintero, G, de la Cámara, J, Candamio, S
Publicado 2010

PB1978: AUTOLOGOUS STEM CELL TRANSPLANTATION AND MAINTENANCE IMPROVES SURVIVAL, IN COLOMBIAN MULTIPLE MYELOMA PATIENTS. ACHO’S RENEHOC REGISTRY REPORT

por Abello, V., Sossa-Melo, C., Idrobo, H., Munevar, I., Quintero, G., Mantilla, W., Borjas, Y., Galvez, K., Gomez, R., Saavedra, J. D., Gaviria, L. M., Reyes, J., Bermudez, C., Herrera, J. M., Martinez, H.
Publicado 2022

PB1845: ACUTE MYELOID LEUKEMIA IN THE ELDERLY: A MULTICENTER EXPERIENCE IN COLOMBIA, ON BEHALF OF ACHO’S RENEHOC INVESTIGATORS

por Sossa-Melo, C., Abello, V., Solano, M., Peña, A., Rosales, M., Quintero, G., Mantilla, W., Salazar, L., Idrobo, H., Reyes, J., Gaviria, L., Bermudez, C., Gomez, R., Correa, M., Herrera, J., Guerrero, P., Galvez, K., Martínez-Cuadrón, D., Sanz, M. A., Montesinos, P.
Publicado 2022

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma...

por Sastre, J., García-Alfonso, P., Viéitez, J.M., Cano, M.T., Rivera, F., Reina-Zoilo, J.J., Salud-Salvia, A., Quintero, G., Robles-Díaz, L., Safont, M.J., La Casta, A., Gil, S., Polo, E., Asensio-Martínez, E., García-Paredes, B., López, R.L., Guillot, M., Valladares-Ayerbes, M., Aranda, E., Díaz-Rubio, E.
Publicado 2021